Serum Institute clarifies, 'Covishield is safe and immunogenic'

New Delhi: Serum Institute of India (SII), a company that makes the corona virus vaccine, said its corona vaccine covidshield is completely safe and immunogenic. Earlier, a person involved in the trial of covidshield, a potential vaccine for Covid-19, accused the Serum Institute of causing severe side effects, including a severe neurological problem and cognitive problem due to his vaccine. However, his allegations were denied by the Serum Institute on Sunday.

Serum Institute says COVID vaccine is safe:

The Serum Institute of India stated that covishield is safe and immunogenic. There was no accident with the volunteer in Chennai due to the vaccine.

The trial followed all regulatory and ethical procedures and guidelines. The Principal Investigator, DSMB and the Ethics Committee said the vaccine test had no connection with its status. The company further said that a legal notice was sent to protect the company's reputation, which is being misrepresented.

ALSO READ: What will be the cost of Coronavirus Vaccine in India?

'Indeed, Serum Institute of India (SII), a company that manufactures the corona virus, on Sunday dismissed allegations of a man involved in the trial of a possible vaccine for Covid-19. The company also threatened to levy heavy fines for making false allegations.

A 40-year-old man who took part in covidShield's trial in Chennai alleged that he suffered serious side effects, including a severe neurological problem and gynocentric problem. The person has demanded compensation of Rs five crore from the Serum Institute and others. It has also demanded a moratorium on the trial.

The Serum Institute of India said in a statement, 'The allegations made in the notice are malicious and false. The Serum Institute of India is sympathetic to the medical condition of the person, but the vaccine test has nothing to do with his condition. ' The company said that the person was wrongly blaming the vaccine for its health problems.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.